Cellvie Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $5M

  • Investors
  • 7

Cellvie General Information

Description

Developer of mitochondria-based therapeutic technology intended to restore cellular bioenergetics and improve organ function. The company utilizes isolated mitochondria derived from donor cells to repair damaged or energy-depleted cells through infusion, enabling the healthcare providers to address conditions linked to mitochondrial dysfunction.

Contact Information

Website
www.cellvie.bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Scotland Street
  • Houston, TX 77007
  • United States
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Drug Discovery
Vertical(s)
Corporate Office
  • Scotland Street
  • Houston, TX 77007
  • United States

Cellvie Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cellvie Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 09-Sep-2025 $5M Completed Pre-Clinical Trials
6. Grant 24-Oct-2024 Completed Pre-Clinical Trials
5. Later Stage VC (Series A) Cancelled Pre-Clinical Trials
4. Seed Round 06-Feb-2023 Completed Pre-Clinical Trials
3. Seed Round 25-Jan-2021 Completed Pre-Clinical Trials
2. Accelerator/Incubator 01-Jun-2020 $25K $25K Completed Pre-Clinical Trials
1. University Spin-Out 01-Jan-2018 Completed Startup
To view Cellvie’s complete valuation and funding history, request access »

Cellvie Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed
To view Cellvie’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Cellvie Patents

Cellvie Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2023283025-A1 Composition and method for cryopreservation of mitochondria Pending 10-Jun-2022
EP-4535996-A1 Composition and method for cryopreservation of mitochondria Pending 10-Jun-2022
US-20250361490-A1 Composition and method for cryopreservation of mitochondria Pending 10-Jun-2022
WO-2023237789-A1 Composition and method for cryopreservation of mitochondria Inactive 10-Jun-2022
AU-2023285014-A1 Mitochondria as a targeted delivery platform Pending 10-Jun-2022 C12N15/87
To view Cellvie’s complete patent history, request access »

Cellvie Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cellvie Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Beiersdorf Venture Capital Corporate Venture Capital Minority
Innosuisse Government
Beiersdorf Corporation Minority
Taiho Ventures Corporate Venture Capital Minority
Kizoo Technology Capital Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Cellvie FAQs

  • When was Cellvie founded?

    Cellvie was founded in 2018.

  • Where is Cellvie headquartered?

    Cellvie is headquartered in Houston, TX.

  • What is the size of Cellvie?

    Cellvie has 10 total employees.

  • What industry is Cellvie in?

    Cellvie’s primary industry is Biotechnology.

  • Is Cellvie a private or public company?

    Cellvie is a Private company.

  • What is Cellvie’s current revenue?

    The current revenue for Cellvie is .

  • How much funding has Cellvie raised over time?

    Cellvie has raised $15.5M.

  • Who are Cellvie’s investors?

    Beiersdorf Venture Capital, Innosuisse, Beiersdorf, Taiho Ventures, and Kizoo Technology Capital are 5 of 7 investors who have invested in Cellvie.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process